World Heart Congress
Trace 1: Interventional cardiology
Andreas Gruentzig is known as the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter which is mainly deals with the catheter based treatment of structural heart diseases. Cannulation the radial-artery also can be used and this method having numerous advantages which consist of the accessibility of the artery in most patients, the easy control of bleeding even in anticoagulated patients, the enhancement of relief because patients are able to sit and walk immediately following the procedure, and the near absence of clinically significant squeals in patients with a normal Allen test. In the other side to this methodology include spasm of the artery & pain, inability to use larger-catheters required in various procedures and also more radiation exposure. Procedures are:
- IVC filter & Pulmonary Embolectomy
- Device closure of Congenital cardiac defects CLI
- Percutaneous Aortic aneurysm repair by stent grafts.
- Renal Angioplasty & Carotid Angioplasty
- Peripheral angioplasty including Sub- Intimal angioplasty
- Angiography/Cardiac path
- Angioplasty Including Complex Angioplasty including chronic total Occlusion
Trace 2: Pediatric Cardiology Cases
Pediatric Cardiology concern all parts of coronary illness in babies, kids, and young people, including embryology and life systems, physiology and pharmacology, organic chemistry, pathology, hereditary qualities, radiology, clinical angles, analytical cardiology, electrophysiology and echocardiography, and heart medical procedure. Pediatric Cardiology is in charge of the analysis of inborn heart surrenders, performing demonstrative methods, for example, echocardiograms, cardiovascular catheterizations and electrophysiology contemplates. The expanding number of neonates with inborn heart absconds alluded to the neonatal emergency unit the expanding mindfulness that the imperfections might be available. Chest radiography and ECG once in a while aid the neonatal conclusion. Congestive heart disappointment in the hatchling, or hydrops, can be recognized by performing fetal echocardiography.
Many of the pediatric heart defects such as:-
- Ligation of collateral vessels
- Pericardial window
- Thoracic duct ligation
- Patent ductus arteriosus interruption
- Ligation of collateral vessels
- Thoracic duct ligation
Trace 3: Cardio-Oncology
Cardio-oncology is a quickly developing field gone for limiting the impacts of cardiovascular bleakness and mortality in cancer survivors. To meet this point, patients are evaluated at standard to characterize their danger of cardio toxicity and after that pursued nearly amid and after chemotherapy to survey for early signs or manifestations of cardiovascular diseases. Cardiovascular imaging, and specifically, transthoracic echocardiography, assumes a fundamental job in the gauge appraisal and sequential follow-up of cardio-oncology patients. The goals of this paper are to survey the systems of cardio toxicity of a few regular chemotherapeutic specialists related with an expanded hazard for left ventricular systolic brokenness and to layout proposals in regards to the pattern appraisal and sequential line up of cardio-oncology patients with an attention on the role of echocardiography.
Trace 4: CardiovascularDisease &Pharmacology
Cardiovascular Diseases (CVD) is a class of diseases that incorporate the heart or veins. Diverse CVDs incorporate stroke, aortic aneurysms, periphery course sickness, thromboembolic infirmity, and venous thrombosis, coronary illness, hypertensive coronary ailment, rheumatic coronary ailment, cardiomyopathy, heart arrhythmia, intrinsic coronary ailment, valvular coronary ailment, carditis, congenital heart disease.
Cardiovascular Pharmacology manages the investigation of the impact of medications upon the heart or the circulatory framework. Cardiovascular Pharmacology and Therapeutics will center essentially around medications utilized in the treatment of cardiovascular sickness, both current medication classes and those being developed. It mostly adds to the wellbeing profile of potential new medications and gives pharmacological information that can be utilized for the advancement of further mixes and a definitive determination of mixes appropriate for clinical improvement.
Trace 5: Cardiovascular Surgeries
Cardiac surgery is generally performed on heart or great vessels. Frequently, it is done to treat the complications of ischemic heart disease, correct congenital heart disease, or treat Valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis are generally treated by this method. The procedures implemented in cardiac surgery are: Aortic Aneurysms & Dissections, Coronary Artery Bypass Grafting, Left Ventricular Assist Device and Heart Transplantation, Mitral Valve Surgery and Open-Heart Surgery etc.
Trace 6: Vascular heart diseases
Vascular heart disease is characterized by damage to or a defect in one of the four heart valves, the mitral, aortic, tricuspid or pulmonary. In vascular heart disease, the valves become too narrow and hardened (stenosis) to open fully or are unable to close completely (incompetent). Valve disease symptoms can occur suddenly, depending upon how quickly the disease develops. Many of the symptoms are similar to those associated with congestive heart failure, such as shortness of breath and wheezing after limited physical exertion and swelling of the feet, ankles, hands or abdomen (edema). The severity of vascular heart disease varies. In mild cases there may be no symptoms, while in advanced cases, vascular heart disease may lead to congestive heart failure and other complications. Treatment depends upon the extent of the disease.
- Aortic and mitral valve disease
- Pulmonary and tricuspid valve diseases
- Congenital heart disease
- Cerebrovascular disease
- Rheumatic heart disease
- Inflammatory heart disease
- Peripheral arterial disease
- Coronary artery disease
Trace 7: Current Research in Cardiology
Cardiology conferences comprises the current research in cardiology contains the new innovative methods that are coming in cardiology related field. In this sub topic we have Statin therapy, Thrombolytic therapy and Cardiac rehabilitation. There are so many associations and societies and the main association for Interventional cardiology is located in USA. Many universities are working on Current Research in Cardiology. Hospitals and Companies around USA are associated with Cardiology. Some research topics in cardiology includes; Electrophysiology and Arrhythmia Research, Myocardial and Heart Failure Research, The Vital Basis of Excitability in the Heart, Genomic Basis for Inherited Cardiovascular Disease, Proteomic Analysis of Heart Disease, Mechanisms of Cardiac Hypertrophy and Remodeling etc.
Trace 8: Geriatric Cardiology
Geriatric cardiology or Cardio geriatrics is the branch of cardiology that deals with the cardiovascular disorders in elderly people. The field of geriatric cardiology reflects the evolving medical approaches tailored to address the needs of the growing population of oldest old with cardiovascular diseases (CVD). Cardiac disorders such as coronary heart disease (including myocardial infarction, cardiomyopathy, heart failure, arrhythmias (as atrial fibrillation) and others are common and are a major cause of mortality in elderly people. Vascular disorders such as atherosclerosis and peripheral arterial disease cause significant morbidity and mortality in aged people.
Trace 9: Cardiac Nursing
Cardiac Nursing has a place with that works with patients who experience the ill effects of different states of the cardiovascular framework. Under the supervision of a cardiologist a cardiac nurse caretaker cures those conditions like unsteady angina, congestive heart disappointment, myocardial dead tissue cardiomyopathy, coronary course sickness and heart dysrhythmia. Cardiac medical nurse are prepared for various practice range, working operation theaters, cardiovascular recovery focuses, cardiovascular consideration focus clinical exploration, including coronary consideration units, heart catheterization, serious patient consideration units, cardiovascular surgery wards, cardiovascular concentrated consideration units and cardiovascular restorative wards
Trace 10: Cardiovascular Engineering
Cardiovascular Engineering encompasses a large vary of medical specialty and engineering comes targeted at understanding the mechanisms and coverings of vessel health, disease, and regeneration. Engineering sciences of fluid dynamics and solid mechanics are integrated with biology and diseases of the heart, heart valves, vasculature, and lymphatics with a rapidly growing emphasis on pediatric cardiovascular diseases. This thrust additionally covers vessel regeneration or repair victimization up-to-date technologies together with stem cells, biomaterials, and nanotechnologies.
Biomedical engineers in our department collaborate with active clinicians and clinical investigators, medical specialty imaging scientists, and basic vessel biologists victimization experimental and process approaches asking queries spanning the genes and small molecules to cellular and organ levels that, in most cases square measure integrative and multi-scale.
Fluid dynamics and mechanics of blood square measure being studied within the heart, heart valves, all major vessels, tube-shaped structure grafts, and therefore the peripheral vasculature victimization in vitro, in vivo, multi-scale. Research related to mechanical heart valves, new bioprosthetic styles, and compound trileaflet valve prostheses is internationally recognized, as is analysis in blood vessel hemodynamics, epithelium cell biology, and their rolesin atherosclerosis and arterial remodeling.
New areas of analysis embrace fluid dynamics of occlusion, aneurysms, and RBC sickness.
- Cardiac Computed Tomography
- Biomedical and Engineering
- Cardiac 3D Imaging
- Intravascular Ultrasound
Trace 11: Myocardial and Pericardial Disease
Damage to the heart muscle most often develops from coronary artery disease (CAD) related myocardial infarction, usually in people in their middle or later decades. Inherited forms of heart muscle disease (Cardiomyopathies) are the most prominent cause of myocardial disease in the young. Myocardial infarction and cardiomyopathies are the major causes of heart failure and arrhythmic sudden death.
Pericardial disease or pericarditis is an inflammation of the pericardium. Pericarditis is characterized by pericardial friction rub (an audible sound of rubbing heard along with the heart beat), chest pain and changes in an electrocardiogram (ECG, test to evaluate the heart failure function). It is seen more commonly in men than in women. Chronic pericarditis may occur due to the recurrence of acute pericarditis or due to a chronic infection such as tuberculosis.
- Ventricular tachycardia
- Supraventricular tachycardia
- Atrial fibrillation
- Ventricular fibrillation
Trace 12: Open-Heart Surgery
Open-heart surgery is any kind of surgery where the chest is cut open and surgery is done on the muscles, valves, or arteries of the heart. Coronary artery bypass grafting is common type of heart surgery which is done on adults. During this type of surgery, a healthy artery/ vein is grafted to a blocked coronary artery. This permits the grafted artery to bypass the blocked artery & bring fresh blood to the heart. Open-heart surgery is also termed as traditional heart surgery. Now days many new heart techniques can be performed with only small incisions, not wide openings.
Trace 13: Echocardiography & Cardiac Imaging
Echocardiography, also called an echo test or heart ultrasound, is a test that takes “moving pictures” of the heart with sound waves. It’s not surgery. Echocardiography uses standard two-dimensional, three-dimensional, and Doppler ultrasound to create images of the heart. It is one of the most widely used diagnostic tests in cardiology. It can provide a wealth of helpful information, including the size and shape of the heart (internal chamber size quantification), pumping capacity, and the location and extent of any tissue damage. Echocardiography can help to detect cardiomyopathies, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and many others.
Cardiovascular imaging is a central aspect of Cardiology. Cardiovascular imaging is the action or process of producing an image especially of a part of the body (Heart) by radiographic techniques. It interprets cross sectional imaging studies of the heart and vascular system. Standard imaging tests include echocardiography (Echocardiography), chest x-ray, CT, MRI, and various radionuclide techniques (Radionuclide Imaging). ‘Conference series LLC Ltd teams with CED, a Joint Accreditation Provider, as Joint Providers of CME Credits for the Cardiology Meetings consisting of physicians, cardiologists, cardiac surgeons, scientists, professors and young researchers
Advances In Cardiovascular imaging:
Advanced cardiac imaging, using cardiac magnetic resonance imaging (MRI) and multi detector computed tomography (CT), is increasingly used in the work-up of athletes with suspected abnormalities on screening. Both imaging modalities produce highly accurate and reproducible structural and functional cardiac information. Cardiac MRI has the advantage of imaging without radiation exposure or the use of iodine-containing contrast agents, but is sometimes not possible due to claustrophobia or other contraindications. Although cardiac MRI can rule out coronary artery anomalies, multi detector CT is superior to cardiac MRI for visualizing the full extent of the coronary arteries and atherosclerotic coronary artery disease. Echocardiography remains the most advanced tool for non-invasive cardiac imaging because of its applicability for most cardiac disorders and its exquisite spatial resolution.
Trace 14: Cardiac and Cardiovascular Research
The Cardiology Meeting supports awareness of the treatment of risk factors for Cardiac disorders. The most comprehensive provider of cardiovascular services for the prevention, detection, treatment and treatment of cardiovascular diseases. This annual cardiology meeting is a platform for postgraduate education and scientific work in the field of cardiology, angiology, hypertension and cardiac and vascular surgery. Reduces clinical events and premature death in people at risk of cardiovascular disease. Cardiovascular disease is treatable in initial treatment primarily focused on nutrition and lifestyle interventions. The medical meeting focuses on the treatment of diseases and new theories of diagnosis of blood vessels and vascular system or heart.
Trace 15: Heart Devices
Heart Devices are electronic devices that help circulate a heart that is used too partially or completely to replace the function of a failing heart. The development of these wireless heart monitors marks a new era in medicine and the transition from healthcare to population levels to personalized medicine where appropriate patients are equipped with advanced biosensors which in turn have their data processed by sophisticated prediction algorithms will happen. Pacemakers, defibrillators, biosensors are cardiac devices used to treat heart disease.
Trace 16: Cardvascular Drugs
Cardiovascular drugs refer to the prescribed medicines which are used to treat the diseases related to the structure and function of the heart and blood vessels. Treatments in this area include heart failure, coronary artery disease, high blood pressure, cardiac arrest, arrhythmia, stroke, congenital heart diseases. These drugs reduce the blood pressure and the heart’s workload. Drugs are included in the classes Vasoconstrictors, Vasodilators, Antihypertensives, Antiarrhythmic agents, Hypolipidemic agents etc.
- ACE inhibitors
- Antiplatelet agents
- Thrombolytic agents
Trace 17: Cardiovascular, Diabetology,Obesity & Stroke
Obesity raises the risk for heart disease and stroke. But it harms more than just the heart and blood vessel system. It is also a major reason of gallstones, osteoarthritis and respiratory problems. Obesity is closely intertwined with numerous health conditions that underlie cardiovascular disease with high blood pressure, diabetes, and irregular blood cholesterol. In addition, weight increase is a frequent result of heart-damaging lifestyle choices such as deficiency of exercise and a fat-laden diet. Obesity also can lead to heart failure. This is a serious situation in which your heart can't pump enough blood to encounter your body's needs. Having diabetes or pre diabetes puts one at increased risk for heart disease and stroke. One can decreased its risk by possession the blood glucose (also called blood sugar), blood pressure, and blood cholesterol close to the recommended target numbers—the levels suggested by diabetes experts for good health. Stroke and coronary heart disease can be caused by the same problem – atherosclerosis
- Diabetic, Metabolic Syndrome and Stroke prevention
- Weight and diabetes
- Metabolic Syndrome and Ischemic Stroke
- Dyslipidemia and risk of Stroke
Trace 18: Cardiac Electrophysiology
Cardiac Electrophysiology deals with the treating and diagnosing the electrical activities of the heart. These studies are performed in order to access the arrhythmias, to evaluate the abnormal electrocardiograms, to access the risk of developing the symptoms and treatment. Cardiac Electrophysiology Study will be measuring the response of the cardiomyopathic myocardium to Programmed Electrical Stimulation in the regimens in order to compare that the regimen will prevent the ventricular fibrillation in future.
- Extracellular Recording
- Bioelectric recognition assay
- Computational electrophysiology
- Intracellular Recording
Trace 19: Anasthesia and cardiac image
General anaesthesia for cardiac MRI is governed by similar principles for any anaesthetic technique in children with heart disease. High-risk imaging refers to imaging in patients with medical or health-related risks, imaging with equipment-related risks, and procedure-related risks such as MRI-guided surgery, minimally invasive procedures. MRI can be performed in patients who have undergone previous cardiac surgery. Absolute contraindications include patients with pacemakers and defibrillators. A Deep sedation or general anaesthesia is indicated in neonates, infants and small children for MRI. The challenges during MRI include limited access to patient and equipment, low ambient temperature with risk for hypothermia and a noisy unfamiliar environment with the remote location from the operating room. Anaesthetic care for magnetic resonance imaging (MRI) as moderate sedation, deep sedation, monitored anaesthesia care, general anaesthesia, or ventilatory and critical care support.
- CT radiation risk
- Cardiac MR imaging
Trace 20: Heart Transplantation In Childeren
A heart transplant is an activity in which a cardiothoracic specialist will supplant your child’s falling flat heart with another contributor heart. Reasons that youngsters would require a heart transplant can be not quite the same as those for grown-ups. Youngsters regularly require transplant as a result of an intrinsic heart deformity (an imperfection that was available during childbirth) and cardiomyopathies (infections of the heart muscle). Like grown-ups, kids additionally can require transplant because of obtained illness.
Trace 21: Cardiac Imaging Techniques
Cardiac imaging is done to diagnose the heart condition by a physician. Medical specialty professional organizations discourage the use of routine cardiac imaging during pre-operative assessment for patients about to undergo low or mid-risk non-cardiac surgery because the procedure carries risks and is unlikely to result in the change of a patient's management. Stress cardiac imaging is discouraged in the evaluation of patients without cardiac symptoms or in routine follow-ups
- Positron Emission Tomography
- Computed tomography angiography
- Magnetic resonance imaging
- Intravascular ultrasound
Trace 22: Cardialogists
A cardiologist is a doctor who specializes in the studies of heart & its functions & also diagnosis, treatment and preventing diseases related to heart and blood vessels. You might also visit a cardiologist so you can learn about your risk factors for heart disease and find out what measures you can take for better heart health. Cardiology is a field which is changing rapidly, new technologies as drug-eluting stents, assist devices for left ventricle, and novel inflammatory markers, and imaging modalities such as magnetic resonance imaging and 3D echocardiography.
- Preventive cardiologists
- Vascular medicine specialists
- Cardiovascular investigators
- Cardiac anesthesiologists
- Electro physiologist
- MR/CT cardiologists
- General clinical cardiologists
- Nuclear cardiologists
- Vascular medicine specialists
- Cardiovascular investigators
- Cardiac anesthesiologists
Trace 23: Womens And Heart Diseases
Heart disease is the main killer of women, causing 1 in 3 deaths each year which counts to approximately 1 woman every minute. There are several misconceptions about heart disease in women, and they could be putting you at risk. Other types of heart disease, such as coronary micro vascular disease (MVD) and broken heart syndrome, also pose a risk for women. These disorders, which mainly affect women, are not as well understood as CHD. Symptoms such as dizziness, palpitations, and syncope are frequent complaints encountered by family physicians, internists, and cardiologists. In contrast to these ubiquitous complaints, which are generally benign, sudden cardiac death remains an important public health concern. In general, the seriousness of cardiac arrhythmias depends on the presence or absence of structural heart disease. This Heart Congress scientific program has been CME and CPD certified.
- Pregnancy complications
- Premature atrial contractions
- Premature ventricular contractions
- Sinus node dysfunction
- Hormone replacement therapy
- Coronary microvascular disease (MVD)
- Broken heart syndrome
- Mental stress and depression
- Smoking realted complications
- Heart disease and stroke prevention in women
- High blood pressure and women
Trace 24: Molecular Cardialogy
Molecular cardiology mainly targets to apply molecular biology practices for the diagnosis, prevention, treatment and mechanistic investigation of cardiovascular disease is a novel and rapid growing area of cardiovascular medicine. Being an emerging field, it has changed conceptual thinking of disease-etiology, pathophysiology and cardiovascular improvement. It has released a promising path for understanding and regulating cardiovascular disease. Scientists are closer to curing heart diseases that were thought to be incurable 20 years ago with the fast development and application of molecular biology techniques. To endorse the progression of stem cell therapy and gene therapy for heart diseases, obviously there is a necessity for thorough understanding of the molecular mechanisms of cardiovascular diseases.
- Stem cell therapy for Cardiovascular Disease
- Gene Analysis in the Injured and Hypertrophied Heart
- Transgenic Techniques in Cardiovascular Research
Trace 25: Cardiomyopathy
Cardiomyopathy refers to diseases of the heart muscle. These diseases have several causes, signs and symptoms additionally as treatments. In most cases, heart disease causes the guts muscle to become enlarged, thick or rigid. In rare instances, pathological cardiac muscle tissue is replaced with connective tissue.
As cardiomyopathy worsens, the heart becomes weaker. The heart becomes less ready to pump blood throughout the body and incapable of maintaining a standard electrical rhythm. The result may be cardiopathy or irregular heartbeats known as arrhythmias. A weakened heart can also cause different complications, like heart valve issues.
The main types of cardiomyopathy are:
- Restrictive cardiomyopathy
- Arrhythmogenic right ventricular dysplasia
- Transthyretin amyloid cardiomyopathy (ATTR-CM)
- Dilated cardiomyopathy
- Hypertrophic cardiomyopathy.
Track 26 : Cardiology- Future Medicine
Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients' expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modelling and information management issues. We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader. Accessible 'at-a-glance' formats are important in an increasingly time-constrained clinical community.
Topics include the following areas:
- New diagnostic approaches, screening and patient stratification
- Therapeutic overviews highlighting optimal therapy and future options
- Real world evidence and outcomes research
- Advanced device and imaging technologies
- Interventional and surgical approaches
- Molecular basis of cardiovascular disease
Trace 27: Diabetic Cardiovascular Disease
The time period diabetic cardiovascular sickness (DCD) refers to heart disorder that develops in human beings who've diabetes which will increase your threat of coronary heart assault and clot-related stroke (cardiovascular events). Peripheral artery disease case wherein your arteries narrow, decreasing blood discharge on your arms and legs additionally will increase your risk of a cardiovascular accident. Diabetes is a sickness in which the frame's blood glucose (sugar) level is too high and affects your body's ability to supply or use insulin. Commonly, your frame turns the meals you devour into electricity. Insulin is launched to useful resource shipping this strength to the cells. Insulin acts as a “key".
- Diabetic cardiomyopathy
- Renal disease
- Diabetes and blood pressure
- Diabetes & cholesterol
- Diabetes and heart diseases
- Renal Artery Stenoses
- Cerebrovascular diseases (stroke)
- Diabetes and stroke
- Diabetes and peripheral arterial disease
Trace 28: Cardiac Surgery
Cardiovascular surgical treatment which is likewise called surgical procedure thoracic surgical procedure is operated on the coronary heart or outstanding vessels by using cardiac surgeons and it is the sector of medicine worried in surgical treatment of organs within the thorax. There are five kinds of cardiac surgical operation 1) Open heart surgery 2) modern beating-coronary heart surgery three) coronary heart transplant 4) Coronary artery skip grafting five) Minimally invasive surgical operation and surgeries are achieved to treat complexity of ischemic heart disease, accurate congenital heart sickness, or treat valvular heart disease from various causes along with endocarditis, rheumatic heart disorder and atherosclerosis and development of cardiac surgical operation and cardiopulmonary bypass strategies has significantly decreased the mortality rates of those strategies. The surgical operation calls for postoperative care to avoid headaches. Laceration care is needed to avoid infection and decrease scarring. Swelling and loss of appetite are not unusual, As mentioned Coronary artery bypass grafting (CABG) is the most commonplace form of coronary heart surgical treatment. CABG improves blood waft to the coronary heart.
- Open heart surgery
- Angioplasty or surgery for multivessel coronary artery disease
- Therapeutic and physiologic issues surrounding heart valve surgery
- Mechanical support left ventricular assist devices
- Surgery for lV dysfunction
- Cardiac transplantation
- Adult congenital heart disease and sports cardiology
- Minimally invasive heart surgery
- Transmyocardial revascularization (TMR)
- Advances in congenital heart disease
- Artificial heart valve surgery
- Bypass surgery
- Heart transplant
Trace 29: Clinical Cardiology
Clinical Cardiology includes studies appertain to cardiac diseases, cardiovascular heart disease, congenital heart diseases, coronary artery disease and their epidemiology and pathophysiology of the heart. The therapeutic procedures involving diagnosis and management of cardiac diseases like cardiovascular devices, cardiac regeneration, cardiac medicine, electrophysiology, cardiac surgery and identification of risk factors for cardiovascular diseases.
- Community Outreach Program
- Enhanced External Counter Pulsation therapy
- Aortic dissection surgery
- Congenital and Pediatric heart surgery
- Aneurysm surgery
- Mitral & Aortic Valve repair & Restoration Surgery Overview
- Peripheral Vascular procedures
- Carotid endarterectomy
- Case Reports on Vascular Heart Disease
- Case Reports on Arrhythmias
- Case Reports on Atherosclerosis
- Case Reports on Heart Regeneration
Trace 30: Congestive Heart Failure
Congestive heart failure (CHF) is a condition in which the function of heart is inadequate to meet the body's needs. The pumping efficiency of heart can be impaired through many diseases by causing the congestive heart failure.
The diagnosis test of CHF is based on knowledge of the selected laboratory tests, individual's medical history and a careful physical examination. The treatment of congestive heart failure includes mechanical therapies, addressing potentially reversible factors, medications, heart transplant and lifestyle modifications. The duration of CHF can be variable in any given patient.
The symptoms of congestive heart failure includes:
- Diminished exercise capacity
- Shortness of breath
- Swelling (edema).
Trace 31: New ways In Cardiovascular Surgery
The future holds dramatic advances that will transform the cardiac surgeon, in part, into an intervention list with new skills in diagnostic and therapeutic approaches to structural heart disease. The cardiovascular surgery has achieved great progress both on scale and technology though development over the past thirty years. However, the technical predominance of cardiovascular surgery in therapies for some diseases has been weakened, along with developments of new drugs and interventional technology. Currently, cardiovascular surgeons should practice the "patient first" principle, carry out individual customized treatment and precision therapy, absorb the advantages of other subjects like intervention and imaging in order to achieve technological breakthroughs, create new treatment technologies and models with smaller trauma and better outcome, establish heart team to provide patient oriented treatment. Besides, cardiovascular surgeons should improve knowledge system by learning related technology and science, become hybrid doctors of research. Cardiovascular surgeons should pay high attention to critical effect of research on the disciplinary development, change the medical practice by virtue of research achievements, direct the treatment for cardiovascular diseases, and finally provide better health service and rebuild the predominance of cardiovascular surgery.
Trace 32: Cardiac Rehabilitation
Cardiac rehabilitation is a multifaceted intervention advised to sufferers identified with heart disease, which incorporates components of fitness schooling, advice on cardiovascular danger discount, physical activity and strain supervision. The Cardiac Rehabilitation affords medically monitored exercising underneath the administration of physiologists. After tremendous assessment and checking out, a physiologist will design an individualized exercise prescription.
- Exercise Based Cardiac Rehabilitation
- Medication Management Based Cardiac Rehabilitation
- Nutritional Assessment and Counselling Based Cardiac Rehabilitation
- Smoking Cessation Coaching Based Cardiac Rehabilitation
- Stress and Anxiety Management Based Cardiac Rehabilitation
Trace 33: Structural Heart Disease Interventions
Structural heart diseases are structural defects in the heart which may be present from the initial stages of birth, which need to be rectified by surgical interventions. Transcatheter techniques applied for treating non-coronary heart diseases are known as structural heart interventions. New opportunities continue to unfold in the field of treating structural heart interventions. The Present day structural heart intervention training programs include both valvular and non-valvular techniques concentrating on a wide range of adult primary congenital heart defects and complex surgical residual
Defects infant population. Many cardiologists prefer a new branch of percutaneous treatment which targets congenital and acquired diseases that were not addressed or were treated in another complex manner. Percutaneous structural heart interventions require a multi-axle approach involving cardiac imaging specialists, clinical cardiologists, interventional cardiologists, pediatricians and expert cardiac surgeons. A thorough assessment on patient procure compatibility has to be made. Continuous enhancement of knowledge and training in materials and devices to be used individual specific procedures is a prerequisite. The catheterization lab in the hospital must be equipped to perform hybrid procedures.
The following structural conditions are grouped together.
- Valvular heart disease
- Vascular obstructions
- Any other conditions
- Septal defects
In continuation to successful past scientific meetings, 27th Edition of International Conference on World Heart Congress, June 15-16, 2020 at Barcelona, Spain, EuroSciCon suggests every single person to attend "World Heart Congress” in the midest of June 15,16, 2020 at Barcelona, Spain which merges brief keynote introductions, speaker talks, Exhibitions, Symposia, Workshops.
World Heart Congress 2020 will gather world-class Cardiologists, Directors, Cardiac Surgeons, Professors, Researchers, Scientists, Nurses and Nurse Practitioners, Anaesthesiologists, Medicine Specialists, Students, Medical Institutions and Universities, Business Professionals and Cardiology Organizations. Educators, Researchers, and Young Researchers working in the related fields to consider, exchange views and their experiences before an extensive worldwide social occasion of individuals. The gathering warmly welcomes Presidents, CEO's, Delegates and specialists from the sector of Cardiology and other pertinent organization positions to take an interest during these sessions, B2B get together and board talks. The assembly of this event is going to be revolving round the topic “Highlighting Latest innovations and challenges in cardiology”. This Cardiology conference mainly focuses on spreading the awareness about challenges in this fields and how to prevent and manage the techniques of Cardiac Imaging, Cardiology and Cardiac nursing. This Cardiology Conference is the annual gathering directed with the help of the Organizing Committee Members and individuals from the Editorial Board of the support in world heart congress related journals and is aimed toward serving to support care professionals.
World Heart Congress 2020 aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical professionals like Directors, Heads, Deans, Professors, Scientists, Researchers, Cardiologists, Founders and Employees of the related companies, Associations, Organizations, Laboratory members and Young researchers working in the field of Cardiology & Heart treatment.
Why to attend?
World Heart Congress 2020 is among the World's driving Scientific Conference, with people from around the world focused on getting some answers concerning Cardiology; this is your single most obvious opportunity to accomplish the greatest cluster of individuals from the crisis facilities, Universities, society, etc. This World Heart Congress 2020 will coordinate shows, scatter information, meet with energy and potential pros and get name affirmation at this 2-day event. Amazingly celebrated speakers, the most recent techniques, procedures, and the most current updates in Pediatric Cardiology field are indications of this social affair. World Heart Congress 2020 will join significant sessions expected to offer clearing sessions that region current degrees of progress in different field of Cardiology. Many distinguished cardiologists, cardiac surgeons’ researchers and scientists will take part in this Conference. Papers will be presented in the form of plenary sessions, symposia and posters and will include superb scientific and clinical material that was carefully selected by the Review Committee. The Conference will provide the ideal forum to stimulate ideas and establish collaborations.
- Open Innovation Challenges.
- Poster presentations by Young Researchers.
- Lectures by unique prospectors.
- Keynote discourses by Prominent Professors, Doctors.
- Excellent stage to include the latest things and definitions in Cardiac field
- Meet the editors of suggested journals, Society and Association people over the Globe.
- Target Audience:
- General Cardiology
- Interventional Cardiology
- Cardiac Surgeons
- Heart Failure
- Clinical EP
- Internal Medicine
- Pediatric Cardiology
- Preventive Cardiology
- Cardio-thoracic Surgery
- Cardiology Imaging
- Emergency Medicine
- Cardiac Oncology
- Cell Biology
- Vascular Medicine
- Cardio Vascular Medicine
- Cardiovascular and Thoracic Surgery Instruments
World Heart Congress 2020 is a two-day conference which is to be held on June 15,16, Barcelona,Spain. This will be a great platform to gather and share knowledge, presentations, panel discussions, interactive dialogue about the developing world of cardiology. This conference brings together the researchers, scientists, professors, students, cardiologists who dispense an international forum on extending of approved research. This will be a great platform to gather and share knowledge, presentations, panel discussions, interactive dialogue about the developing world of cardiology.Cardiovascular disease is the major cause of deaths affecting lives all over the world. These diseases are primarily related with heart and blood vessels disorders, such as ischemic heart disease, stroke, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease, hypertension and others. These disorders are mainly reported due to obesity, high cholesterol, unhealthy dietary habits, lack of physical activity, smoking, excessive alcohol, and poor lifestyle. According to the World Health Organization (WHO), CVD is responsible for approximately 15 million deaths each year across the globe and it also states that it is a major cause of death in adults that accounts for 50% of total deaths worldwide. The high risk of heart disease in the region can also be attributed to an inadequate and the high consumption of fat and carbohydrates. Some of the other factors causing Cardiovascular Disease are • Being physically inactive • Being overweight or obese • Ancestors of heart disease • Ethnical background • Sex – men are more likely to develop cardiovascular disease at an earlier age than women. • Age – the older you are, the more likely you are to develop cardiovascular disease (CVD).
The global cardiovascular device market is estimated to reach $69.3 billion by 2022, and it is forecast to grow at a CAGR of 4.3% from 2017 to 2022. This market growth is primarily driven by the growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population. The key opportunities for this market are increasing product launches and a large number of mergers and acquisitions between cardiovascular devices manufacturing companies across the world. However, lack of skilled professionals to operate these devices, stringent regulations & legislations, and a high cost of the devices & their maintenance are the key challenges faced by the market. These result in unfavourable market conditions for new players. The market is segmented geographically into North America, Europe, Asia-Pacific and Rest of the World. North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region. The U.S leads the North American market, followed by Canada. Asia-Pacific signifies the fastest growing region for global cardiovascular devices, due to the growing geriatric population and increasing awareness about various cardiovascular devices. Some of the important Companies Mentioned in the Global Cardiovascular Devices are MAQUET GmbH & Co. KG, Sorin Group, Medtronic Inc., EndoPhotonix Inc., Terumo Corporation, SEMMT Inc., C. R. Bard Inc., Cardima
Scope and Importance:
The aim of this gathering is to invigorate new thoughts for treatment and to analyze the current market for the future bearing of cardiovascular medicines, gadgets, and diagnostics, with an accentuation on more up to date items that will be advantageous over the range of cardiology. Lectures will give a far-reaching best in the class refresh of the clinical employments of different strategies in the conclusion, visualization, and administration of basic heart diseases. As the world is ending up progressively against general wellbeing difficulties and dangers for heart diseases bursts. This Conference gives an interesting chance to Academic pioneers, teachers and, clinicians and in addition for specialists and researchers of advanced education from everywhere throughout the world to con-vane and offer original thoughts on critical issues and patterns in the area of cardiology.
Growth of Interventional Cardiology Market:
The global interventional cardiology advertise is probably going to develop at a CAGR of 6.9% (2017-2022) bringing about a worldwide income of USD 21.88 billion by 2022. The interventional cardiology showcase is ready to develop at an enduring rate over the gauge time frame given that the utilization of interventional cardiology gadgets has expanded altogether. Public as well as private sector hospitals have begun utilizing interventional cardiology items. The stents, and in addition catheters portion, are relied upon to develop at a huge rate. The improvement of advanced minimally invasive procedures and increment in the selection of the equivalent in interventional cardiology is probably going to drive the worldwide market later on. Besides, the advancement of crossover strategies is another pattern that is probably going to pick up acknowledgment over the business in the coming years. Expanding number of individuals with heart diseases around the globe ascend in the populace, and development of pediatric heart diseases are a portion of alternate factors that are relied upon to push the advancement of the general interventional cardiology market in a development direction. In spite of the idealistic development forecast of the interventional cardiology showcase, some limiting components must be thought about while investigating the general market situation. Post-procedural complexities, for example, blood coagulating or thrombosis, uneven medication discharge, and changing rates of corruption are a portion of the components that may block the development of the market. Also, the market situation of interventional cardiology is exceptionally powerful. The force of competition among companies is reasonably high. Value cuts offered by little and medium players on their gadgets constrain built up players to decrease their profit revenues.
UniversityofPennsylvania | Stanford University| Cardiology Conferences| University of Michigan| University of Rochester| University of Washington| Yale University | Washington University | Heart Disease Conferences | Duke University School of Medicine | Paediatrics Conferences | UCSF School of Medicine | University of Michigan Medical School | The University of Pittsburgh School of Medicine | Vanderbilt University School of Medicine | Harvard University| Cardiology Conferences | Johns Hopkins University | Heart Disease Conferences| Columbia University | Ohio State University | Northwestern University | Baylor College of Medicine | University of Colorado | University of Cincinnati | Cardiology Conferences | Heart Conferences
European Cardiology Universities
LudwigMaximilians University | Heart Disease Conferences | University of Amsterdam | University of Vienna | Cardiology Conferences | University of South Wales | University of Liverpool | University of Brighton | University of the West of Scotland | UCL (University College London) | University of Oxford | University of Edinburgh | University of Cambridge | University of Leeds | St George's, University of London | Plymouth University | Cardiology Conferences | Heart Disease Conferences | University College Cork| Trinity College Dublin | Heidelberg University | Rwth Aachen University| Leipzig University |
University of Tokyo | National University of Singapore | Kyoto University | Pediatrics Conferences | Seoul National University | University of Malaya | Universiti Putra Malaysia| Heart Disease Conferences | University of Tokyo | National University of Singapore | Kyoto University | Peking University| Tsinghua University | Weizmann Institute of Science | Osaka University | Seoul National University | Shanghai Jiao Tong University | Fudan University | Zhejiang University | Pediatrics Conferences | Tel Aviv University | Hebrew University of Jerusalem | University of Hong Kong | Tohoku University | Nanyang Technological University | Korea Advanced Institute of Science and Technology | Hokkaido University | National Taiwan University | Keio University | Shandong University | Nagoya University | Sungkyunkwan University | Yonsei University | Heart Disease Conferences | Kyushu University | Sun Yat-sen University | Huazhong University of Science and Technology | Wuhan University| EuroSciCon | University of Science and Technology of China| Cardiology Conferences | Tokyo Institute of Technology | King Abdulaziz University | National Cheng Kung University | Kobe University | Korea University | Pohang University of Science and Technology | Indian Institute of Science | Nankai University | Tongji University | King Saud University | Nanjing University | Harbin Institute of Technology | University of Tsukuba | Kyung Hee University | Sichuan University |Xiamen University | Chonnam National University | Jilin University | Central South University | University of Tehran | Aligarh Muslim University | Chinese University Hong Kong | University of Delhi | South China University of Technology | Waseda University | Okayama University | Pediatrics Conferences | Southeast University | Soochow University | Mahidol University | Hiroshima University | Cardiology Conferences | Tianjin Medical University | Kanazawa University | Heart Disease Conferences | Tehran University of Medical Sciences |Kumamoto University | Kyungpook National University | National Yang-Ming University | China Medical University Taiwan
University of Queensland Australia | University of Melbourne | University of Sydney | Monash University | Cardiology Conferences | Heart Conferences | University of New South Wales| University of Western Australia | University of Auckland | University of Otago | University of Adelaide | Australian National University | Heart Disease Conferences | University of Queensland Australia | Major Pediatric Cardiology Societies| Romanian Society of Cardiology | Danish Society of Cardiology | Cardiology Conferences | The American Heart Association | British Cardiovascular Society | Asian Pacific Society of Cardiology | The Pan-African Society of Cardiology (PASCAR) | Pediatrics Conferences | Latin American Society of Interventional Cardiology | European Society of Cardiology | American Society of Nuclear Cardiology | Canadian Cardiovascular Society | British Congenital Cardiac Association (BCCA)| The American Society for Preventive Cardiology | Arizona Society of Echocardiography | Argentine Society of Cardiology | Canadian Association of Interventional Cardiology | International Academy of Cardiology | The Japanese Heart Failure Society | Pediatrics Conferences | Lebanese Society of Cardiology| British Heart Failure Society |Belorussian Scientific Society of Cardiologists | Heart Disease Conferences |
Related Conferences to Cardiology
15th Cardiology Conference, February 19-20, 2018 Paris, France | 3rd Cariology Conference, May 07-08, 2018 Frankfurt, Germany | 12th Heart Conference, July 13-14, 2018 Toronto, Canada | Pediatrics Conferences | 14th Cardiology Conference, June 14-16, 2018 Rome, Italy | 17th Cardiology Conference | 16th Heart Conference, March 21-22, 2018 (14 Forums, 2 Days, 1 Event) New York, USA | 23rd Cardiology Conference, February 19-21, 2018 Paris, France | Heart Disease Conferences | 4th Heart Conference, September 14-15, 2018 Singapore | EuroSciCon Conferences | 27thCardiology Conference, September 21-22, 2018 Van Couver, Canada | 27th Cardiology Conference, October 22-24, 2018 Rome, Italy | Cardiology Conferences |World Heart Conference, May 16-17, 2018 Montreal, Canada | 24thCardiology Conference, June 11-13, 2018 Barcelona, Spain | 11th World Heart Conference, August 16-17, 2018 Singapore
The Children's Hospital of Philadelphia | Boston Children's Hospital | Cincinnati Children's Hospital Medical Center | Children's Hospital of Wisconsin, Milwaukee | Children's Hospital Colorado, Aurora | Children's Hospital of Pittsburgh of UPMC | Texas Children's Hospital, Houston| University Hospital Munich | University Hospital Heidelberg | Saskatoon City Hospital, Saskatchewan | St. Joseph’s Health Care, London, Ontario | Covenant Health Banff Mineral Springs Hospital, Banff, Alberta | Chaleur Regional Hospital, Bathurst, New Brunswick | Victoria General Hospital, Winnipeg, Manitoba | The Royal Melbourne Hospital | New South Wales hospital, Goulburn| Johns Hopkins Hospital, Baltimore | Northwestern Memorial Hospital, Chicago | New York-Presbyterian Hospital
Consultant Cardiology/General Medicine, Isle of Man Government | Pediatrics Conferences | Clinical Research Fellow, University of Leicester | Heart Disease Conferences | Consultant Cardiologist, Abertawe Bro Morgannwg University Health Board | Specialty Doctor Cardiology, Southern Health and Social Care Trust | LAS ST3 Cardiology, Abertawe Bro Morgannwg University Health Board| Attending Physician, Children's Hospital of Philadelphia | Pediatric Cardiology Outreach Physician, UT Southwestern Medical Center | Assistant Professor, Baylor College of Medicine | Pediatric Echo Sonographer, University of Florida | Neonatologist, Mednax | Pediatrician, County of San Mateo | Pediatric General Physician, Kendall & Davis | Senior Pre-Clinical Trial Manager, Square One Pharma | Physician, Corizon Physician | Pediatrician, Prospect Medical Holdings Connecticut Region | Physician Developmental Peds, Kaiser Permanente | Physician Pediatrics Practice, Western Maine Health | Physician - Pediatric Medicine, Franciscan Health |
Hellenic Journal of Cardiology | International Journal of Cardiology | The American Journal of Cardiology | Canadian Journal of Cardiology| Heart Disease Conferences | Journal of Molecular and Cellular Cardiology | Journal of Cardiology | New devices and technology in interventional cardiology | Journal of Congenital Cardiology | Adherence to the European Society of Cardiology| JACC (Journal of the American College of Cardiology) | Clinical Trials and Regulatory Science in Cardiology | International Journal of Cardiology | Current Problems in Cardiology | Cardiology Clinics | The Journal of Pediatrics | International Journal of Pediatrics and Adolescent Medicine | Egyptian Pediatric Association Gazette | Journal of Pediatric Surgery Case Reports | Journal of Pediatric Surgery |